Webinars

COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patients from America

COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patients from America

On June 1st, TIF representatives, Dr Androulla Eleftheriou and Dr Michael Angastiniotis and Mr Loris Brunetta, Board Member, had a fruitful discussion with patient advocates from the AMRO region about…
COVID-19 & Haemoglobin Disorders: The Impact of Coronavirus on Sickle Cell Disease Patients

COVID-19 & Haemoglobin Disorders: The Impact of Coronavirus on Sickle Cell Disease Patients

An Expert Panel of Six Medical Professionals from various countries, such as India, the UK, Italy and Saudi Arabia, shared their experiences with TIF on the impact of the COVID-19…
eThalED Webinar Series: Access to New Therapies – Reblozyl

eThalED Webinar Series: Access to New Therapies – Reblozyl

The 1st webinar for Medical Specialists organised in the context of TIF’s eThalED online course is here. Dr Antonio Piga, Professor of Paediatrics & Dean of the Medicine School at…
The Patients’ Perspective on the Accessibility & Affordability of Novel Therapies for Thalassaemia

The Patients’ Perspective on the Accessibility & Affordability of Novel Therapies for Thalassaemia

9 patients with thalassaemia, members of TIF’s Patient Advocacy Group for Thalassaemia and Sickle Cell Disease (T-PAG), are discussing with the Thalassaemia International Federation the accessibility and affordability of the…
COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patient Advocates from Europe

COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patient Advocates from Europe

Patient Advocates from Greece, Germany, the UK, the Netherlands, Romania and other countries of the WHO European Region exchange thoughts and opinions with TIF about the daunting challenges and concerns…
COVID-19 & Haemoglobin Disorders: The Cyprus Webinar

COVID-19 & Haemoglobin Disorders: The Cyprus Webinar

In the context of TIF’s intensive efforts for the accurate and timely information of individuals with thalassaemia and sickle cell disease (SCD) in relation to the COVID-19 pandemic, the Federation…
Maldivian Thalassaemia Society ITD2020 Webinar: The Impact of COVID-19 on Thalassaemia

Maldivian Thalassaemia Society ITD2020 Webinar: The Impact of COVID-19 on Thalassaemia

The Maldives Thalassaemia Society, a TIF Member Association, hosted a live Webinar on the 8th o May to commemorate the International Thalassaemia Day 2020, with the active participation of Dr…
TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients

TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients

On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled ”Thalassaemia/SCD and COVID-19: Possible risks and a proposal for a patient pathway during…
Back to top button